Article
Genetic modification and preconditioning strategies to enhance functionality of mesenchymal stromal cells: a clinical perspective
19 Apr 2023
Abstract excerpt
INTRODUCTION: Mesenchymal stromal cell (MSC)-based therapy has generated great hope for the treatment of various diseases such as myocardial infarction and stroke. Unfortunately, MSC-based therapy faces major hurdles in its translation to clinical practice. To address these issues, preconditioning and genetic modification strategies have been developed. Through preconditioning, MSCs are cultured under sub-lethal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
